[
  {
    "ts": null,
    "headline": "Trump Says Drug Tariffs Are Coming. Big Pharma Execs Can’t Figure Out How Much to Worry.",
    "summary": "The Trump administration said in mid-April to expect tariffs on drug imports in a month or so, which puts the deadline sometime in the next few weeks.",
    "url": "https://finnhub.io/api/news?id=15f4a2ff0607c6619e78dabd1dfa023a6f335354b43315ea0fc387f3657e6202",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746206340,
      "headline": "Trump Says Drug Tariffs Are Coming. Big Pharma Execs Can’t Figure Out How Much to Worry.",
      "id": 134204352,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The Trump administration said in mid-April to expect tariffs on drug imports in a month or so, which puts the deadline sometime in the next few weeks.",
      "url": "https://finnhub.io/api/news?id=15f4a2ff0607c6619e78dabd1dfa023a6f335354b43315ea0fc387f3657e6202"
    }
  },
  {
    "ts": null,
    "headline": "Zacks.com featured highlights Fox, Universal Technical Institute, Pfizer, Tenet Healthcare and Newmont",
    "summary": "Fox, Universal Technical Institute, Pfizer, Tenet Healthcare and Newmont have been highlighted in this Screen of The Week article.",
    "url": "https://finnhub.io/api/news?id=bf0a903fe7272e9e86fa6f755ef603ea0e8a31ed27e23a542c7349d0ffdeda15",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746190740,
      "headline": "Zacks.com featured highlights Fox, Universal Technical Institute, Pfizer, Tenet Healthcare and Newmont",
      "id": 134184955,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Fox, Universal Technical Institute, Pfizer, Tenet Healthcare and Newmont have been highlighted in this Screen of The Week article.",
      "url": "https://finnhub.io/api/news?id=bf0a903fe7272e9e86fa6f755ef603ea0e8a31ed27e23a542c7349d0ffdeda15"
    }
  },
  {
    "ts": null,
    "headline": "Why The Low Payout Ratio Did Not Stop The Dividend Cut For Organon",
    "summary": "Organon stock cut their dividend by over 90%. There are lessons here for all income investors. Click here to find out what income investors need to know.",
    "url": "https://finnhub.io/api/news?id=4e16ad76cd7fda98777b06d445f7f29349431cdcd21668fec46e78c5e347c473",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746180010,
      "headline": "Why The Low Payout Ratio Did Not Stop The Dividend Cut For Organon",
      "id": 134184342,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1460500012/image_1460500012.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Organon stock cut their dividend by over 90%. There are lessons here for all income investors. Click here to find out what income investors need to know.",
      "url": "https://finnhub.io/api/news?id=4e16ad76cd7fda98777b06d445f7f29349431cdcd21668fec46e78c5e347c473"
    }
  },
  {
    "ts": null,
    "headline": "3 No-Brainer Ultra-High-Yield Dividend Stocks That Are Begging to Be Bought in May",
    "summary": "Three supercharged income stocks -- sporting an average yield of 8.63% -- are perfectly positioned to fatten investors' pocketbooks.",
    "url": "https://finnhub.io/api/news?id=77791a8bc3464ac7314bd5481f9c5846afb16f5795b6ea4c23ed5085c16c2e43",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746172260,
      "headline": "3 No-Brainer Ultra-High-Yield Dividend Stocks That Are Begging to Be Bought in May",
      "id": 134184870,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Three supercharged income stocks -- sporting an average yield of 8.63% -- are perfectly positioned to fatten investors' pocketbooks.",
      "url": "https://finnhub.io/api/news?id=77791a8bc3464ac7314bd5481f9c5846afb16f5795b6ea4c23ed5085c16c2e43"
    }
  },
  {
    "ts": null,
    "headline": "Build Your Own ATM: 2 Undervalued Dividend Machines Yielding 7%",
    "summary": "Strategic investing beats market predictions. Read here for two stocks that offer reliable income, strong business models, and long-term potential.",
    "url": "https://finnhub.io/api/news?id=dd6d6dd73ee6c3ee3b4196218f9d70bb161dc3ca9000e80b4245ec09e83de7d4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746171000,
      "headline": "Build Your Own ATM: 2 Undervalued Dividend Machines Yielding 7%",
      "id": 134183296,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/960131070/image_960131070.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Strategic investing beats market predictions. Read here for two stocks that offer reliable income, strong business models, and long-term potential.",
      "url": "https://finnhub.io/api/news?id=dd6d6dd73ee6c3ee3b4196218f9d70bb161dc3ca9000e80b4245ec09e83de7d4"
    }
  },
  {
    "ts": null,
    "headline": "Arvinas Inc (ARVN) Q1 2025 Earnings Call Highlights: Record Revenue Surge and Strategic ...",
    "summary": "Arvinas Inc (ARVN) reports a significant revenue increase and outlines strategic moves to extend its cash runway and enhance its drug development pipeline.",
    "url": "https://finnhub.io/api/news?id=9f5b7ffaed8d395a35e283cfe9707465fedae76f1b7344e6c72509872b524eda",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746169389,
      "headline": "Arvinas Inc (ARVN) Q1 2025 Earnings Call Highlights: Record Revenue Surge and Strategic ...",
      "id": 134184957,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Arvinas Inc (ARVN) reports a significant revenue increase and outlines strategic moves to extend its cash runway and enhance its drug development pipeline.",
      "url": "https://finnhub.io/api/news?id=9f5b7ffaed8d395a35e283cfe9707465fedae76f1b7344e6c72509872b524eda"
    }
  }
]